pharmaphorum

AUGUST 12, 2024

Journal retracts three articles on MDMA-assisted psychotherapy, shortly after FDA blocks approval of @Lykos_PBC's therapy for PTSD

108

108

STAT

SEPTEMBER 24, 2024

STAT is co-publishing this article by Tradeoffs. Lisa Ann Trainor struggled to stay on top of schoolwork, hold a job or even perform basic tasks like laundry for six exhausting years. Then, in 2018, she finally found a drug that kept her ADHD in check.    Continue to STAT+ to read the full story…

Drug Pricing 359

Drug Pricing Drug Development 359

STAT

DECEMBER 11, 2023

The journal will also publish review articles, policy perspectives, and educational materials for physicians and computer scientists. Many recent articles published in top-tier journals have envisioned a future state where AI transforms vast swaths of medical practice.

354

354

STAT

JUNE 22, 2024

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

362

362

STAT

OCTOBER 15, 2024

Nearly all of them, as a related article details, pointed to a crisis in primary care.    Over the last few months, STAT put that question to nearly a dozen experts in cardiology, primary care, endocrinology, and vascular disease.   Read the rest…

332

332

STAT

OCTOBER 31, 2023

This article was adapted from STAT’s latest report , “Subgroup analysis: how to evaluate post hoc tests for significance in failed clinical trials.” ” C linical trials of newly developed drugs often don’t work out. Read the rest…

339

339

STAT

JANUARY 10, 2023

Cell, EMBO, and Science have each opened their own investigations into the articles, and both Science and Cell have published “editorial expressions of concern” for the papers, which warn readers that the information in the articles may be questionable, but stop short of making corrections or retractions.

341

341

STAT

SEPTEMBER 28, 2023

This article is adapted from STAT’s exclusive analysis in the STAT Report: “Climate rankings: How top drug companies measure up in combating climate change.” ” D rug companies are major contributors to climate change, both through direct greenhouse gas emissions and especially through their supply chains.

353

353

STAT

JUNE 29, 2024

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

315

315

STAT

JULY 6, 2024

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

302

302

STAT

MAY 3, 2023

“I’ve been pursuing the same enemy for 25 years,” Skovronsky, now head of research at Eli Lilly, said at the STAT Breakthrough Summit in San Francisco on Wednesday.

347

347

STAT

SEPTEMBER 21, 2024

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

Compounding 301

Compounding 301

STAT

JUNE 13, 2023

This article was co-published with The Markup , a nonprofit newsroom that investigates how powerful institutions are using technology to change our society. Sign up for its newsletters here.

321

321

STAT

JUNE 26, 2024

“Some of the findings of the article are affected and the corresponding conclusions are no longer supported,” Nature said in the retraction. Nature retracted a high-profile paper that served as part of the scientific groundwork for Micronoma, a San Diego-based startup, on Wednesday.

320

320

STAT

MAY 6, 2024

Abrams asked Juul officials for talking points, allowed company executives to review an academic article prior to publishing, and attended Juul scientific advisory board meetings, all without disclosing those connections to journal publishers or the public. Continue to STAT+ to read the full story…

Documentation 363

Documentation 363

STAT

JUNE 25, 2024

O’Donnell in an article in The New England Journal of Medicine. Called administrative harm, it directly influences patient care and outcomes, professional practice, and organizational efficiencies. The term was coined in 2022 by physician Walter J.

321

321

STAT

AUGUST 24, 2024

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

280

280

STAT

APRIL 18, 2024

The issues with this paper, along with concerns with more than 50 other articles co-authored by four of Dana-Farber’s top researchers, were highlighted in a January blog post by the scientific sleuth Sholto David.

362

362

STAT

JULY 20, 2024

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

Drug Pricing 278

Drug Pricing 278

STAT

FEBRUARY 23, 2024

In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists.

245

245

STAT

OCTOBER 25, 2023

Visit the website of cardiologist Ruey Hu, and you can scroll through his prolific scientific articles neatly arranged into 11 sections by study type, peruse a folder of medical education resources, and browse links to a couple of hand-coded tools. More curiously, there’s also a tab labeled, “Composing.”

Labelling 328

Labelling 328

STAT

NOVEMBER 15, 2022

For one, the first article about the biotech and its $3 billion stash talked about Silicon Valley billionaires “ living forever.” BOSTON — The executives behind Altos Labs would really, really like people to stop saying they’re trying to reverse aging. They have a couple things going against them on this count.

302

302

STAT

SEPTEMBER 7, 2024

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

Vaccines 269

Vaccines 269

STAT

AUGUST 10, 2024

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

269

269

STAT

AUGUST 3, 2024

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

Vaccines 269

Vaccines 269

STAT

OCTOBER 28, 2023

Recently, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. It’s called, appropriately, STAT+ Connect.

262

262

STAT

AUGUST 17, 2024

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

266

266

STAT

MAY 5, 2023

Read the rest…

320

320

STAT

OCTOBER 26, 2024

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

Hospitals 263

Hospitals 263

STAT

JUNE 15, 2024

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

Vaccines 261

Vaccines 261

STAT

MAY 13, 2024

” The answer invariably comes back to a popular 2003 journal article from a quartet of health economists titled, “ It’s The Prices, Stupid.” ” Continue to STAT+ to read the full story…

Hospitals 336

Hospitals 336

STAT

OCTOBER 10, 2023

This article is part of a partnership between First Opinion and Tradeoffs, a podcast exploring our confusing, costly, and often counterintuitive health care system. To

297

297

STAT

JULY 12, 2024

Grave warnings of a crisis in maternal deaths are being slightly eroded by articles suggesting that advocates overreached and that the “crisis” was primarily a function of measurement error. Both sides are partially right, because measuring maternal mortality is uniquely challenging.

Medical Records 284

Medical Records 284

STAT

MAY 19, 2023

Amid increased concerns over a lack of transparency in clinical trials, a new study found that one in five primary endpoints were changed after a late-stage study had begun, and 70% of the trials examined did not include information about primary endpoint changes in articles published in medical journals.

329

329

STAT

OCTOBER 18, 2024

On a lunch break during one of his clinical rotations, he was sitting in the cafeteria reading the school’s newsletter when he stopped, struck by an article on the first page. In medical school at Vanderbilt University, however, Chern was so busy that his violin sat untouched in his closet until one afternoon in his third year.

Medical Schools 308

Medical Schools 308

STAT

MARCH 27, 2023

This article is excerpted from the latest STAT Report: Treating Depression: a new era of promising Drugs. O n May 8, 1972, a researcher at Eli Lilly in Indianapolis named Jong-Sin Horng tested a compound his team had developed and found it had a curious property. Read the rest…

Compounding 246

Compounding 246

STAT

MARCH 17, 2023

Under this policy, most JAMA articles remain accessible only to subscribers, but authors can publicly post their manuscripts the day they are published, and they are not charged open access fees as many journals do.

339

339